
NORTH CHICAGO, Illinois — Walgreens Boots Alliance Inc (WBA.O), the owner of the Walgreens drugstore chain, reported weaker-than-expected quarterly results on Friday and gave a disappointing forecast, sending its shares down 6%.
The company said net income fell to $380 million, or $1.08 per share, in the quarter ended May 31, from $669 million, or $1.89 per share, a year earlier. Analysts on average had expected earnings of $1.10 per share, according to Refinitiv data.
Walgreens said U.S. pharmacy sales declined 3.9% due to lower sales of generic drugs and a shift in business from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. fell 2.3%.
The company's shares were down 6% at $44.60 in morning trading.
Walgreens also said it expects full-year earnings to be between $4.30 and $4.45 per share, below analysts' average estimate of $4.47 per share.
The results come as Walgreens continues to face pressure from competition in the pharmacy sector, particularly from Amazon.com Inc (AMZN.O), which has been expanding its own pharmacy services.
Walgreens Chairman and Chief Executive Officer Doug McMillon said the company is "executing against our strategic priorities" but acknowledged that "the macro environment remains challenging." (Reporting by Sanjana Sastry in Boston; Editing by Will Dunham and Nick Zieminski)
崾 complains of unsatisfactory quarterly performance and lowered its outlook, causing its shares to drop 6%.
Walgreens reported a net income of $380 million, or $1.08 per share, for the quarter ended May 31, down from $669 million, or $1.89 per share, in the same period a year earlier.
The company attributed the decline to lower U.S. pharmacy sales, which fell 3.9% due to decreased sales of generic drugs and a shift from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. decreased by 2.3%.
Walgreens also announced an outlook for full-year earnings between $4.30 and $4.45 per share, below the analysts' average estimate of $4.47 per share.
The company faces ongoing pressure from competitors like Amazon, which has been expanding its pharmacy services.
Walgreens Chairman and CEO Doug McMillon stated, "We are executing against our strategic priorities," but acknowledged the challenging macro environment.
Shares of Walgreens were trading down 6% at $44.60 in morning trading.
Walgreens #QuarterlyResults #EarningsReport #StockMarket #RetailPerformance
一夜之间,联大和安理会涉乌投票格局为何大变?
央视新闻客户端
多方恶意抢注DeepSeek商标被驳回,专家解读→
中国之声
商务部新闻发言人就加拿大以涉俄为由制裁中国企业答记者问
商务部网站
从《定军山》到《哪吒2》,我们能看到什么?
新华社
杜江峰任教育部副部长,齐家滨任国家公务员局局长
人社部网站
我国自主研制!全球最大功率甲醇双燃料船用发动机正式发布
央视新闻
网店售卖银行土,一份售价数十元 律师:商家发布含迷信的内容或面临处罚
红星新闻
高校副院长被指出轨女博士生,校方通报:免职,暂停工作
南京师范大学网站
日本妄图制造“一中一台” 国台办:作为负有历史罪责的国家 应慎重处理涉台问题
央视新闻客户端
赵女士走了,叔姑舅姨9人争遗产,房产为何收归国家?案例释法→
央视新闻